Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda Herrera

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphomaOlivier Gaide, Fernanda Herrera, Wendy Jeanneret Sozzi, et al.
Radiation Oncology (London, England)|October 18, 2019
Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practiceCedric Panje, Thomas Zilli, Alan Dal Pra, et al.
Frontiers in Cellular and Infection Microbiology|April 17, 2026
The interplay between probiotics and mast cells in gut inflammation: a mini-reviewMaria Fernanda Herrera-Saldivar, Norma Carolina Hernandez-Bautista, Juan Manuel Quiroga-Garza, et al.
Cancers|June 19, 2024
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II StudyMinna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 29, 2017
Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practiceAlan Dal Pra, Cedric Panje, Thomas Zilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II StudySusana Banerjee, Eleonora Ghisoni, Anita Wolfer, et al.
The Lancet. Oncology|March 5, 2026
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapyAntonio Angrisani, Youlia Kirova, Azadeh Abravan, et al.
Revue Medicale Suisse|December 1, 2021
[Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]Caroline Codeluppi, Françoise Ninane, Laura Jolliet, et al.
Clinical Oral Investigations|June 3, 2019
Systemic and local effects of radiotherapy: an experimental study on implants placed in ratsMariana Raquel da Cruz Vegian, Bruno César Almeida Costa, Gabriela de Fátima Santana-Melo, et al.
Gynecologic Oncology|June 2, 2026
Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98]Giorgio Bogani, Kathleen N Moore, Isabelle Ray-Coquard, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphomaOlivier Gaide, Fernanda Herrera, Wendy Jeanneret Sozzi, et al.
Radiation Oncology (London, England)|October 18, 2019
Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practiceCedric Panje, Thomas Zilli, Alan Dal Pra, et al.
Frontiers in Cellular and Infection Microbiology|April 17, 2026
The interplay between probiotics and mast cells in gut inflammation: a mini-reviewMaria Fernanda Herrera-Saldivar, Norma Carolina Hernandez-Bautista, Juan Manuel Quiroga-Garza, et al.
Cancers|June 19, 2024
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II StudyMinna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 29, 2017
Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practiceAlan Dal Pra, Cedric Panje, Thomas Zilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II StudySusana Banerjee, Eleonora Ghisoni, Anita Wolfer, et al.
The Lancet. Oncology|March 5, 2026
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapyAntonio Angrisani, Youlia Kirova, Azadeh Abravan, et al.
Revue Medicale Suisse|December 1, 2021
[Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]Caroline Codeluppi, Françoise Ninane, Laura Jolliet, et al.
Clinical Oral Investigations|June 3, 2019
Systemic and local effects of radiotherapy: an experimental study on implants placed in ratsMariana Raquel da Cruz Vegian, Bruno César Almeida Costa, Gabriela de Fátima Santana-Melo, et al.
Gynecologic Oncology|June 2, 2026
Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98]Giorgio Bogani, Kathleen N Moore, Isabelle Ray-Coquard, et al.
Pageof 6